The addition of trastuzumab and pertuzumab to chemotherapy was associated with increased toxicity in patients with ...

Therapies that specifically target HER2 include Herceptin (trastuzumab), Perjeta (pertuzumab), and T-DM1 (trastuzumab emtansine) which is sold under the brand name Kadcycla. Treatment of early ...

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

The primary analysis of KATHERINE, a phase 3, open-label trial, showed that the risk of invasive breast cancer or death was 50% lower with adjuvant trastuzumab emtansine (T-DM1) than with ...

blockade with trastuzumab and pertuzumab with the current standard of care, taxane plus trastuzumab and pertuzumab, in HER2-positive metastatic breast cancer (MBC). Compared with the taxane-based ...

Giredestrant is a new type of hormone treatment. It blocks the hormone oestrogen. Pertuzumab and trastuzumab are usual treatments for breast cancer that has tested positive for HER2. The combination ...

And, in fact, this study showed that the additional palbociclib to this kind of treatment was able to significantly prolong ...

Goa is making significant strides in healthcare with initiatives like the Cancer Screening Abhiyan, which has benefited ...